Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
1642 - 1644
Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.
Humans, Alanine, Adenosine Monophosphate, Intensive Care Units, South Africa, COVID-19, SARS-CoV-2